BMJ TAG: making meaningful contributions to patient care
In the last year, the BMJ Technology Assessment Group (BMJ-TAG) has played a key role in evaluating the safety and effectiveness of drugs for public use through the NHS, contributing to the development of high profile NICE guidance. In July 2023, rimegepant was recommended for use in the NHS ...

